Status:

RECRUITING

Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study

Lead Sponsor:

Intermountain Health Care, Inc.

Collaborating Sponsors:

SomaLogic, Inc.

Conditions:

Health Behavior

Eligibility:

All Genders

40-80 years

Phase:

NA

Brief Summary

Feasibility Study Informed consent will be obtained using an IRB-approved form. The first 12 consenting patients will be placed in the planned assessment group for feasibility and will not be randomiz...

Eligibility Criteria

Inclusion

  • Male or female 40 - 80 years of age
  • Receiving care at Intermountain Medical Center
  • At higher than typical risk for cardiovascular events, as assessed by the Principal Investigator or his/her delegate (further defined in the protocol)
  • Currently not pregnant
  • Ability to understand and sign a written informed consent form which must be obtained prior to initiation of any study procedures
  • Willing and able to comply with any virtual or in-person follow-up visits, tests, and schedule of evaluations
  • Willing and able to undergo a blood draw for SomaSignal Tests
  • Willing and able to provide access to their electronic health records

Exclusion

  • Presence of Systemic Lupus Erythematosus
  • Inability to communicate appropriately
  • Participation in any other clinical trials involving investigational or marketed products within 30 days prior to entry in the study
  • Other conditions that in the opinion of the Principal Investigator and/or Co-Principal Investigators may increase risk to the participants and/or compromise the quality of the clinical trial
  • The Principal Investigator and/or Co-Principal Investigator determine(s) that the participant is not eligible for participation in this research study.

Key Trial Info

Start Date :

August 12 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

August 12 2025

Estimated Enrollment :

200 Patients enrolled

Trial Details

Trial ID

NCT04836117

Start Date

August 12 2021

End Date

August 12 2025

Last Update

May 24 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Intermountain Medical Center

Salt Lake City, Utah, United States, 84107

Evaluating the Impact of SomaSignal Tests on Medical Management and Change in Risk in Patients at Higher Risk of Cardiovascular Disease: A Feasibility and an Adaptive Implementation Study | DecenTrialz